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Summary
Objectives: To estimate case fatality rates (CFR) of bacterial meningitis and analyze factors
associated with mortality due to bacterial meningitis in the Italian region of Lazio.
Methods: Patients reported with bacterial meningitis during the period 1996—2000, who died
within 30 days from hospitalization (cases), were compared with survivors (controls) for factors
related to healthcare. Age, gender, residence, bacterial agent, co-morbidities, and signs of
disease severity were also analyzed in the final model. Healthcare factors were analyzed using
current surveillance databases.
Results: Disease severity (OR = 8.84; 95% CI = 3.35—23.34) and age >44 years (OR = 4.59; 95%
CI = 2.01—10.48) were the risk factors most strongly associated with death, while treatment in an
infectious diseases ward was a protective factor, although modified by patient residence and by
co-morbidities.
Conclusions: This protective effect was possibly due to differences in treatment protocols
between the infectious diseases ward and other wards. The protective effect was found to be
stronger for residents of Rome, suggesting delayed access to infectious diseases wards for non-
residents. The difference in risk of dying frommeningitis at younger ages than that found in other
studies should be further evaluated, using information on bacteria serogroups and antibiotic
susceptibility.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Bacterial meningitis is a public health problem, as despite
progress in antibiotic therapy, mortality rates have not* Corresponding author. Tel.: +39 06 83060486;
fax: +39 06 83060463.
E-mail address: faustini@asplazio.it (A. Faustini).
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doi:10.1016/j.ijid.2005.12.004decreased in recent decades.1,2 Age is the strongest predic-
tor of bacterial meningitis mortality.3—6 Other factors influ-
encing mortality are the etiological agent, sepsis, the time
elapsed to sterilize CSF cultures,3,7,8 and other clinical fea-
tures such as altered mental status, hypotension, and sei-
zures.2,4,6
Co-morbidities such as diabetes, cancer,5 and chronic
debilitating diseases3,4 have been reported to be negativePublished by Elsevier Ltd. All rights reserved.
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failed to show the association of these diseases with fatal
outcomes.6 Mortality rate studies have shown the importance
of co-morbidities in causing death in patients with infectious
diseases. Other authors have maintained that co-existing
chronic conditions contribute to most deaths occurring in
patients with bacterial infections when the underlying cause
was coded as an infectious disease.9
A few papers have studied factors related to the manage-
ment of meningitis patients, such as type of treating hospi-
tal10 and antimicrobial therapy. The timing of appropriate
therapy and pre-admission use of antibiotics emerged as the
most important factors associated with fatal outcome.2,6,8
Although no randomized trials have been performed on the
effect of pre-hospital antibiotic treatment, recommenda-
tions have been implemented suggesting immediate treat-
ment with benzylpenicillin for any suspected case of
bacterial meningitis in adults.11
We conducted a study of risk factors for death in patients
with bacterial meningitis, carried out in the Lazio region of
Italy from 1996 to 2000, using surveillance databases.
Methods
A case—control study was designed that enrolled all patients
reported to the surveillance system with bacterial meningitis
from 1996 to 2000. All meningococcal diseases were
included, both meningitis and sepsis, according to surveil-
lance definitions; meningitis due to Mycobacterium tubercu-
losis was excluded, as well as patients with bacterial
meningitis from outside the region.
Case definition
Death due to bacterial meningitis was defined as a confirmed
or probable case of bacterial meningitis reported to the Lazio
surveillance system from 1996 to 2000, registered as
deceased at the General Registry Office, and who died during
the hospitalization in which meningitis was diagnosed, or at
home within 30 days from hospital admission with bacterial
meningitis listed as cause of death.
A confirmed case of meningitis was defined as a patient
with clinical signs such as fever and/or headache and/or neck
stiffness with a positive culture or antigen latex agglutination
test of cerebrospinal fluid (CSF) or blood. Gram-negative
results from microscopic examination were also accepted
as meningococcal disease. A probable case of bacterial
meningitis was defined as a patient with the above-men-
tioned clinical signs and polymorphonuclear pleocytosis in
the CSF (1000/mm3 leukocytes or more), without bacterial
growth in blood or CSF cultures. We excluded meningitis
cases that were not confirmed by the laboratory.
We defined the meningitis as nosocomial when the patient
had already been hospitalized for other causes in the 1—25
days before the onset of symptoms; if the patient was not
hospitalized during this period, we defined the disease as
community meningitis.
In the Hospital Discharge Abstract Registry (HDAR), the
index hospitalization was defined as the admission during
which the meningitis was diagnosed. Information on intra-
hospital deaths was obtained, after considering patienttransfers. The Nominative Cause Mortality Registry (NCMR)
was used to detect deaths from bacterial meningitis outside
the hospital. The International Classification of Diseases,
Ninth Revision (ICD-IX) codes we used were 027.0, 036.0,
036.1, 036.2, 320.0, 320.1, 320.2, 320.3, 320.7, 320.8, and
320.9.
Control definition
We selected as controls all the confirmed or probable cases
of bacterial meningitis who were discharged alive following
the hospitalization in which meningitis was diagnosed and
survived more than 30 days after hospital admission. Con-
trols had to meet the same criteria as cases to be included:
they had to be residents in the Lazio region and had to be
reported to the surveillance system during the same period
of time.
Factors analyzed and data sources
The risk factors we studied related to patient management.
We did not hypothesize which of them had the greatest
impact.
Among those related to the hospital structure we analyzed
hospital classification, presence of an infectious diseases
ward, and hospital location. Hospital classification was based
on the total number of diagnosis-related groups (DRGs) in one
year and the number of surgical and medical specialty ser-
vices offered by each (Regional Law No. 2069/1999), class 1
being those with the highest number of different DRGs dis-
charged and the most specialty services offered.
Among factors related to the quality of healthcare, we
analyzed timing of the hospitalization, patient transfer dur-
ing the illness, and the characteristics of hospitals involved.
The timing of the hospitalization was defined as the time
elapsed between the onset of symptoms, as reported on the
notification form, and the first hospitalization. Patients who
developed meningitis during a hospitalization for other
causes were assigned zero as time elapsed from the onset
of symptoms.
We selected the following factors as possible confounders
of the association between healthcare received and mortal-
ity due to bacterial meningitis: bacterial agent, disease
severity, year of notification, residence, and patient char-
acteristics such as gender, age, and co-morbidities.
Co-morbidities analyzed included diagnoses of cirrhosis
cancer, acquired immunodeficiency (HIV-AIDS), immunode-
ficiency due to absence or extremely low levels of serum
globulins, autoimmune diseases, chronic renal failure, con-
genital or hypoplastic neutropenia, diabetes, and hemor-
rhagic diathesis only in meningococcal disease. Both index
and previous hospitalizations were used to detect co-mor-
bidities.
Disease severity was reported only from the index hospi-
talization, and was defined by the presence of shock and/or
focal neurological signs, such as seizures, and/or pneumonia
if meningitis was due to Streptococcus pneumoniae.
Data analysis
The association between death and each factor was
estimated through odds ratios (ORs) and 95% confidence
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Table 1 Factors associated with death in meningitis cases, Lazio, Italy, 1996—2000
Patients OR 95% CI
Total Dead Alive
n % n %
Factor of infection and patient characteristics
Total 525 98 427
Gender
Female 238 42 42.9 196 45.9 1
Male 287 56 57.1 231 54.1 1.13 0.73—1.76
MI 0
Age group (years)
0—4 164 12 12.2 152 35.6 1
5—24 93 9 9.2 84 19.7 1.36 0.55—3.35
25—44 87 14 14.3 73 17.1 2.43 1.07—5.52
45—64 97 26 26.5 71 16.6 4.64 2.21—9.72
>64 83 37 37.8 46 10.8 10.19 4.91—21.14
MI 1 0 1 0.2
Residence
Rome 302 64 65.3 238 55.7 1
Lazio, outside Rome 223 34 34.7 189 44.3 0.67 0.42—1.06
107—20 000 inhabitants 108 14 14.3 94 22.0 0.55 0.30—1.04
>20 000 inhabitants 115 20 20.4 95 22.3 0.78 0.45—1.36
Notification year
1996 105 19 19.4 86 20.1 1
1997 86 14 14.3 72 16.9 0.65 0.34—1.26
1998 103 15 15.3 88 20.6 0.58 0.28—1.18
1999 120 22 22.4 98 23.0 0.51 0.25—1.01
2000 111 28 28.6 83 19.4 0.67 0.35—1.25
Bacterial agent
Neisseria meningitidis 97 13 13.3 84 19.7 1
Haemophilus influenzae 72 5 5.1 67 15.7 0.48 0.16—1.42
Streptococcus pneumoniae 142 39 39.8 103 24.1 2.45 1.23—4.88
Streptococcus 28 8 8.2 20 4.7 2.58 0.94—7.07
Staphylococcus 14 4 4.1 10 2.3 2.58 0.71—9.47
Listeria 25 8 8.2 17 4.0 3.04 1.09—8.46
Other bacteria 26 3 3.1 23 5.4 0.84 0.22—3.21
Not isolated 121 18 18.4 103 24.1 1.13 0.52—2.44
Focal neurological signs without co-morbidities
No 458 93 94.9 365 85.5 1
Yes 8 3 3.1 5 1.2 2.35 0.55—10.03
MI 59 2 2.0 57 13.3
Shock without co-morbidities
No 451 85 86.7 366 85.7 1
Yes 15 11 11.2 4 0.9 11.84 3.68—38.10
MI 59 2 2.0 57 13.3
Pneumonia without co-morbiditiesa
No 125 37 94.9 88 85.4 1
Yes 5 2 5.1 3 2.9 1.59 0.25—9.88
MI 12 0 12 11.7
Any serious disease sign without co-morbidities
No 438 80 81.6 358 83.8 1
Yes 28 16 16.3 12 2.8 5.97 2.72—13.10
MI 59 2 2.0 57 13.3
Co-morbiditiesb
No 418 71 72.5 347 81.3 1
Yes 60 25 25.5 35 8.2 3.49 1.97—6.19
MI 47 2 2.0 45 10.5
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Table 1 (Continued )
Patients OR 95% CI
Total Dead Alive
n % n %
Healthcare management factors
Total 525 98 427
Etiological diagnosis
Yes 402 79 80.6 323 75.6 1
No 123 19 19.4 104 24.4 0.75 0.43—1.29
MI 0
Classification of first hospital
1st class 283 46 46.9 237 55.5 1
2nd class 166 35 35.7 131 30.7 1.38 0.84—2.24
3rd class 49 12 12.2 37 8.7 1.67 0.81—3.45
4th class 22 5 5.1 17 4.0 1.51 0.53—4.31
MI 5 0 5 1.2
Site of first admission
Rome 372 74 75.5 298 69.8 1
Lazio, outside Rome 148 24 24.5 124 29.0 0.78 0.47—1.29
MI 5 0 5 1.2
Infectious diseases service in the first hospital
No 164 46 46.9 118 27.6
Yes 356 52 53.1 304 71.2 0.43 0.28—0.69
MI 5 0 5 1.2
Classification of last hospital
1st class 333 61 62.2 272 63.7 1
2nd class 168 30 30.6 138 32.3 0.97 0.60—1.57
3rd class 7 3 3.1 4 0.9 3.34 0.73—15.33
4th class 2 2 2.0 0 NC
MI 15 2 2.0 13 3.0
Site of last admission
Rome 424 83 84.7 341 79.9 1
Lazio, outside Rome 86 13 13.3 73 17.1 0.73 0.39—1.38
MI 15 2 2.0 13 3.0
Infectious diseases service in the last hospital
No 43 26 26.5 17 4.0 1
Yes 467 70 71.4 397 93.0 0.12 0.06—0.22
MI 15 2 2.0 13 3.0
Hospital transfer
No 355 59 60.2 296 69.3 1
Yes 170 39 39.8 131 30.7 1.49 0.95—2.35
Kind of hospital transferc
No transfer 355 59 60.2 296 69.3 1
From class 2 to class 1 60 13 13.3 47 11.0 1.39 0.71—2.72
From class 1 to class 1 in Rome 73 20 20.4 53 12.4 1.89 1.05—3.40
From class 1 outside Rome to class 1 inside Rome 23 2 2.0 21 4.9 0.48 0.11—2.09
MI 14 4 4.1 10 2.3
Timing of hospitalizationd
Within 24 h 93 18 18.4 75 17.6 1
1—3 days 170 25 25.5 145 34.0 0.72 0.37—1.40
4—30 days 65 14 14.3 51 11.9 1.14 0.52—2.50
MI 197 41 41.8 156 36.5
MI, missing information. NC, not calculable.
a Only in pneumococcal meningitis (total cases = 142).
b Co-morbidity conditions were defined as present when the patient had one of the following: liver cirrhosis (five patients), cancer (26
patients), autoimmune diseases (0 patients), immunodeficiency, both acquired (five patients), and agammaglobulinemia (three patients),
chronic renal failure (three patients), neutropenia (0 patients), diabetes (20 patients), previous splenectomy performed (one patient).
c Hospital class was reclassified: class 1 includes 1st and 2nd.
d Time elapsed from symptoms to admission.
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Table 2 Adjusted odds ratios of death in patients with
bacterial meningitis, Lazio, Italy, 1996—2000 (number of
observations = 455)
Factor ORa 95% CI
Age
5—44 years 1.55 0.63—3.79
45 years 4.59 2.01—10.48
Streptococcus pneumoniae
in CSF or blood
1.44 0.60—3.42
Bacteria in CSF or blood other
than Neisseria meningitidis and
Streptococcus pneumoniae
1.09 0.43—2.74
Presence of serious disease signs 8.84 3.35—23.34
Treatment in infectious diseases wards
If resident in Rome and:
co-morbidities no 0.05 0.02—0.18
co-morbidities yes 0.40 0.06—2.62
If resident outside Rome and:
co-morbidities no 0.53 0.04—6.70
co-morbidities yes 3.85 0.31—48.63
Site of last admission
outside Rome
0.67 0.26—1.72
Second class last hospital 8.06 0.36—181.4
a Adjusted for all other factors.intervals (CIs). Unconditional logistic regression was car-
ried out, which focused on healthcare-related factors as
exposure variables and assessed the modifying and the
confounding effect of factors related to infection and
patient characteristics such as age, gender, residence,
bacterial agent, co-morbidities, and disease severity.
The multivariable analysis included age and gender along
with any other variable associated with a p value of 0.1 or
less. The timing of hospitalization was excluded from the
model because of the high percentage of missing values.
Some of the variables were reclassified into groups: age
into three groups: 0—4, 5—44, and 45 years; residence into
two: inside and outside Rome; bacterial agent into Neisseria
meningitidis, Streptococcus pneumoniae, other bacteria,
and not identified; hospital class into two groups, the first
included the 1st and 2nd classes, and the second group
included the 3rd and 4th.
We used the likelihood ratio test (LRT) to select the final
models. Finally, separate models were built excluding dis-
ease severity, the strongest predictor of fatal outcome, to
test if it interacted with the other determinants. Stata
software (Version 7, Stata Corporation, Texas) was used for
data analysis.
Results
Six hundred and two cases of bacterial meningitis were
reported in the Lazio region from 1996 to 2000; 525 were
resident in the region (population 5 209 486), 77 were resi-
dent outside the region. Of the 525 resident cases, 404 were
confirmed and 121 were probable cases. There were 98
patients who died from bacterial meningitis according to
our case definition, 95 of whom died in hospital and three
at home. The information about in-hospital death was
obtained from the HDAR in 94 cases, and from notifications
in one case for which the index hospitalization was not found.
Among the three cases that died at home, only two had been
previously hospitalized. The index hospitalization was iden-
tified for 466 (89%) patients, 96 of whom had died. Informa-
tion about hospitalizations for an additional 54 cases was
obtained from notifications.
Univariable analysis (Table 1) showed that the risk of
dying increased with age, doubling the ORs in each age
group. No important differences were detected between
males and females. The risk of dying was higher when the
disease was due to Listeria (OR = 3.04; 95% CI = 1.09—8.46)
or Streptococcus pneumoniae (OR = 2.45; 95% CI = 1.23—
4.88), when shock was among the clinical signs
(OR = 11.84; 95% CI = 3.68—38.10), and when co-morbidities
were present (OR = 3.49; 95% CI = 1.97—6.19). Among the
associated healthcare-related factors, being treated in a
hospital with an infectious diseases ward, both at the first
(OR = 0.43;95% CI = 0.28—0.69) and last hospitalization
(OR = 0.12; 95% CI = 0.06—0.22), had protective effects;
transfer after the first admission increased the risk
(OR = 1.49; 95% CI = 0.95—2.35), especially when both were
Roman hospitals in the highest class. The timing of hospita-
lization was not associated with risk of death, but the
percentage of missing information is very high (41.8%) for
this variable. None of the 14 patients with nosocomial
infections (two had been hospitalized 65 and 83 days before)died. When only community meningitis cases were analyzed
the estimate of fatal outcome decreased from 0.72 to 0.58
(OR = 0.58; 95% CI = 0.28—1.23) in patients hospitalized 1—3
days after the onset of symptoms compared with those
admitted the same day.
The multivariable analysis (Table 2) showed that disease
severity was the most important factor associated with fatal
outcome (OR = 8.84; 95% CI = 3.35—23.34). Other risk factors
were being over 44 years of age (OR = 4.59; 95% CI = 2.01—
10.48) and being admitted to a lower ranked treating hospi-
tal, which had a strong though not statistically significant
association (OR = 8.06; 95% CI = 0.36—181.4). Hospitalization
in an infectious diseases ward remained an important pro-
tective factor against death due to bacterial meningitis, but
only when the patient did not have co-morbidities and
resided in Rome (OR = 0.05; 95% CI = 0.02—0.18). When the
patient resided in Rome but presented co-morbidities
(OR = 0.40; 95% CI = 0.06—2.62) or when he did not present
co-morbidities but resided outside Rome (OR = 0.53; 95%
CI = 0.04—6.70) the effect was still protective though weaker
and not statistically significant. Finally, being treated in an
infectious diseases ward increased the risk of death in
patients who both resided outside Rome and presented
serious co-morbidities (OR = 3.85; 95% CI = 0.31—48.63)
(Table 2).
The factors associated with meningitis death did not
change when we excluded disease severity from the model
(Table 3), nor did the meaning of their association. The same
results were observed even when the analysis was restricted
to patients with less severe meningitis, but the risk of death
was higher for patients over 44 years of age and when co-
morbidities were present (Table 4).
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Table 3 Adjusted odds ratios of death in patients with
bacterial meningitis, Lazio, Italy, 1996—2000 (number of
observations = 467)
Factor ORa 95% CI
Age
5—44 years 1.41 0.60—3.29
45 years 4.08 1.89—8.83
Streptococcus pneumoniae in CSF
or blood
1.66 0.73—3.77
Bacteria in CSF or blood other
than Neisseria meningitidis
and Streptococcus pneumoniae
1.09 0.45—2.61
Treated in infectious disease wards
If resident in Rome and:
co-morbidities no 0.05 0.02—0.17
co-morbidities yes 0.35 0.05—2.31
If resident outside Rome and:
co-morbidities no 0.80 0.07—8.74
co-morbidities yes 5.03 0.39—64.10
Site of last admission outside Rome 0.56 0.23—1.37
Second class of last hospital 6.23 0.33—116.5
a Adjusted for all other factors. Serious disease signs were
excluded from the model.
Table 4 Adjusted odds ratios of death in patients with
bacterial meningitis and without serious disease signs, Lazio,
Italy, 1996—2000 (number of observations = 429)
Factor ORa 95% CI
Age
5—44 years 1.72 0.65—4.55
45 years 5.19 2.12—12.71
Streptococcus pneumoniae in CSF
or blood
1.65 0.65—4.18
Bacteria in CSF or blood other
than Neisseria meningitidis
and Streptococcus pneumoniae
1.18 0.45—3.12
Treated in infectious disease wards
If resident in Rome and:
co-morbidities no 0.05 0.02—0.18
co-morbidities yes 0.38 0.06—2.47
If resident outside Rome and:
co-morbidities no 0.64 0.05—8.27
co-morbidities yes 4.50 0.36—56.61
Site of last admission outside Rome 0.68 0.27—1.77
Second class of last hospital 9.44 0.40—220.7
a Adjusted for all other factors.Discussion
The results indicate that being treated in an infectious
diseases ward was the strongest determinant of surviving
bacterial meningitis. The protective association is remark-
able even after adjusting for risk factors related to infec-tion and host characteristics, although only in patients who
resided in Rome and who did not present co-morbidities. A
possible implication of this result is that treatment was
suboptimal in non-infectious diseases areas. The associa-
tion between outcome and hospital classification strength-
ened this result; the probability of death from meningitis
was higher when the treating hospital was in the lower
rated group, none of which had infectious diseases services.
A previous paper reported that specialized treatment ser-
vices in hospital can serve as a protective factor for fatal
outcomes in meningococcal meningitis; the authors
hypothesized that the association was due to differences
in treatment protocols.10 Furthermore, lower case fatality
rates from meningococcal disease have been reported in
association with admitting all children with meningitis to
one pediatric hospital equipped with an intensive care
unit.12
The protective effect of infectious diseases wards was
lower when co-morbidities were present, as expected, but in
non-Roman residents affected by co-morbidities this effect
was no longer protective, and actually was associated with
higher mortality. A reverse causation may have occurred
here; many of these patients were transferred to specialized
hospitals in Rome when clinical conditions were severe, but
the transfer seems to have occurred too late. Other observa-
tions support this hypothesis, in fact, hospital transfer was
associated with fatal outcome in the univariable analysis, and
the probability of death observed in hospitals outside Rome
was lower than in hospitals in Rome, though the former
include fewer infectious diseases wards. Although our inter-
pretation of these results should be tested more extensively,
they suggest the possibility that treatment at hospitals spe-
cializing in the treatment of meningitis has an impact on
survival, and access to these hospitals is more likely for
residents of Rome than for residents outside Rome.
It has been maintained in the medical literature that the
later the meningitis is diagnosed and treated, the greater is
the possibility of adverse outcomes. Although this assumption
is widely supported, there are papers that report conflicting
results. Timing of antibiotic therapy was associated with
adverse outcomes, both death and neurological deficit, only
in patients who started treatment in advanced clinical stages
of the disease;2,8 the duration of symptoms before therapy
did not have an impact in another study;4 finally, children
with very short courses of the disease had a worse clinical
picture than those with longer courses, characterized by
seizures and coma,13 and a fulminating form of meningitis
showed a strong association with death.6 One possible con-
clusion is that the most severe forms of meningitis, rapid
admission and therapy notwithstanding, show a high risk of
fatal outcome, while meningitis characterized by less severe
signs could improve with rapid diagnosis and care. We ana-
lyzed the timing of hospitalization as a proxy of these factors
and did not find any association. Although the high percen-
tage of missing information could influence this result, the
risk of fatal outcome was lower in patients who presented
symptoms for more than one day before admission, and was
even lower when analysis was restricted to community
meningitis.
Finally, we could not study the pre-admission antibiotic
therapy because this information is not reported in any
database. This intervention has been reported as an
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coccal disease with a risk estimate of 0.09 ( p value = 0.003)6
and is currently recommended by a consensus statement for
any case of suspected bacterial meningitis in adults.11
Among factors linked with infection and host character-
istics, the strongest predictor of fatal outcome was the
presence of serious disease signs, as expected, based on
the literature.2—6,8 Although we found a risk of dying as high
as 11.84 for shock, other studies have reported values up to
18.1 and 39.7.6,8 For focal neurological signs (seizures) and
pneumonia, we found weaker associations as well, consistent
with previous papers,2,5 but with lower estimates of risk. The
use of information from the dataset instead of from clinical
charts could account for this difference.
Another important risk factor of dying from meningitis
was being 45 years of age or older. Older age is a known risk-
factor for meningitis death but in most studies the thresh-
old has been 60 years.1,4—6 Only one study showed higher
risk in patients over 40 years of age, but it analyzed
meningococcal diseases during outbreaks.10 Our results
should be evaluated further using clinical data with infor-
mation on bacteria serogroups and antibiotic susceptibility.
In a previous study14 we estimated a much higher percen-
tage (78%) of N. meningitidis strains intermediately resis-
tant to penicillin in our region than in other countries (3% in
the USA and 40% in Spain).
Co-morbidities were selected according to risk factors of
adverse clinical outcomes in patients with bacterial menin-
gitis of other studies;2,4—6,8 we used a validated co-morbidity
index that allowed us to include underlying diseases or
conditions that might alter the risk of short-term mortality.15
Unfortunately, since information was gathered from data-
bases, meningitis cases occurring in the first year had a lower
probability of being classified by the presence of co-morbid-
ities than those cases reported in the second year of the study
period based on previous hospitalizations.
S. pneumoniae was the most common cause of bacterial
meningitis in our region and it was associated with a slightly
higher risk of death. A similar epidemiologic picture was
reported in other countries16 and in studies focused on
community-acquired bacterial meningitis.2 Where nosoco-
mial diseases are prevalent, Gram-negative bacillary menin-
gitis is reported more frequently than pneumococcal
meningitis.1,5 This could indicate that hospital meningitis
was under-represented among our cases.
Our study presents possible limitations. First of all they
concern the case definition. The definition of bacterial
meningitis included only officially reported cases, and may
be an underestimate. Twenty-six additional cases of bacterial
meningitis were not reported to the surveillance system, and
therefore were not included in the analysis. This lack of
sensitivity was due to fatalities: out of 26 cases not reported,
15 were registered with the cause of death as bacterial
meningitis, and 11 died in hospital with either a primary
or secondary diagnosis of bacterial meningitis. Although the
same inclusion criteria were used in other studies,17,18 the
differences in reporting deaths could have introduced a bias
in analyzing factors related with fatal outcome in our study.
The definition of a bacterial meningitis death is even more
disputable; out of the 98 deaths reported, 45 had a different
underlying cause of death listed, and 23 in-hospital deaths
did not have bacterial meningitis listed as either the primaryor secondary diagnosis. Our definition included a time criter-
ion; the choice of a 30-day time span was intended to detect
deaths due to acute meningitis or its immediate complica-
tions. Although the same criteria have been used in other
studies to define bacterial meningitis death,1,18 other
authors have suggested a 14-day time span to discriminate
between deaths attributable to meningitis and those to other
causes,4 and even a 7-day time span has been used by others
to define bacterial meningitis death.6 We used a 30-day time
period only for patients who had died at home; the survival
time was longer than 30 days in 13 cases who died in hospital,
ranging from 32 to 156 days. This choice could have intro-
duced a bias, because patients who died from complications
of meningitis may have been includedmore frequently if they
died in hospital.
We did not use volume of patients treated as an indicator
of healthcare quality, though it is used frequently for chronic
diseases. The number of meningitis admissions does not
depend on anything but demand, strictly connected to the
characteristics of infection and transmission of bacteria.
Conclusions
Being treated in infectious diseases wards was a protective
factor for patients with bacterial meningitis who did not
present co-morbidities. This protective effect was not shown
for residents outside Rome, possibly due to delayed access to
infectious diseases wards for these patients. Further con-
firmation of this hypothesis could lead to better care man-
agement of meningitis cases and possibly improve prognosis.
We also found a higher probability of dying from bacterial
meningitis when specific clinical conditions were present,
known as predictors of fatal outcome, for older patients or
those with concurrent co-morbid diseases. The coherence of
these results with those of previous studies allows us to be
more confident in our conclusions about healthcare-related
factors in the treatment of bacterial meningitis.
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